首页 产品目录 分子砌块 按反应类型 氨基甲酸酯合成 (2R,3S,4S,5R,6S)-2-((((2S,3R,4R,5S)-3,4-二羟基-5-(((2S,3R,4S,5R)-3,4,5-三羟基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-6-(((S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-(((2R,3R,4S,5S,6R)-4,5-二羟基-6-(羟甲基)-3-(((2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-12-羟基-4,4,8,10,14-五甲基六氢化-1H-环戊并[a]菲-17-基)-6-甲基庚-5-烯-2-基)氧基)四氢-2H-吡喃-3,4,5-三醇

(2R,3S,4S,5R,6S)-2-((((2S,3R,4R,5S)-3,4-二羟基-5-(((2S,3R,4S,5R)-3,4,5-三羟基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-6-(((S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-(((2R,3R,4S,5S,6R)-4,5-二羟基-6-(羟甲基)-3-(((2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-12-羟基-4,4,8,10,14-五甲基六氢化-1H-环戊并[a]菲-17-基)-6-甲基庚-5-烯-2-基)氧基)四氢-2H-吡喃-3,4,5-三醇

(2R,3S,4S,5R,6S)-2-((((2S,3R,4R,5S)-3,4-Dihydroxy-5-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-6-(((S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-(((2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-12-hydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methylhept-5-en-2-yl)oxy)tetrahydro-2H-pyran-3,4,5-triol

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 99% 询价
- +
5mg 99% 询价
- +
10mg 99% 询价
- +
25mg 99% 询价
- +
50mg 99% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

83459-41-0

中文名称

(2R,3S,4S,5R,6S)-2-((((2S,3R,4R,5S)-3,4-二羟基-5-(((2S,3R,4S,5R)-3,4,5-三羟基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-6-(((S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-(((2R,3R,4S,5S,6R)-4,5-二羟基-6-(羟甲基)-3-(((2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-12-羟基-4,4,8,10,14-五甲基六氢化-1H-环戊并[a]菲-17-基)-6-甲基庚-5-烯-2-基)氧基)四氢-2H-吡喃-3,4,5-三醇

英文名称

(2R,3S,4S,5R,6S)-2-((((2S,3R,4R,5S)-3,4-Dihydroxy-5-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-6-(((S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-(((2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-12-hydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methylhept-5-en-2-yl)oxy)tetrahydro-2H-pyran-3,4,5-triol

别名

Ginsenoside Ra1;(3beta,12beta)-12-Hydroxy-20-[(O-beta-D-xylopyranosyl-(1-4)-O-alpha-L-arabinopyranosyl-(1-6)-beta-D-glucopyranosyl)oxy]dammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside;β-D-Glucopyranoside, (3β,12β)-12-hydroxy-20-[(O-β-D-xylopyranosyl-(1→4)-O-α-L-arabinopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]dammar-24-en-3-yl 2-O-β-D-glucopyranosyl-;Ginsenoside Ra1,inhibit,Inhibitor,Ginsenoside Ra 1,Ginsenoside Ra-1;(2R,3S,4S,5R,6S)-2-((((2S,3R,4R,5S)-3,4-Dihydroxy-5-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-6-(((S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-(((2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-12-hydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methylhept-5-en-2-yl)oxy)tetrahydro-2H-pyran-3,4,5-triol

标准英文名

(2R,3S,4S,5R,6S)-2-((((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-6-(((S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-(((2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-12-hydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methylhept-5-en-2-yl)oxy)tetrahydro-2H-pyran-3,4,5-triol

MDL No.

MFCD09970547

分子式

C58H98O26

分子量

1211.40

精确分子量

1210.63

SMILES

C[C@]12[C@]3([C@@]([C@H](O)C[C@]1([H])[C@@]4([C@@](C(C)([C@@H](O[C@@]5([H])[C@@H]([C@H]([C@H](O)[C@@H](CO)O5)O)O[C@]6([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]6O)CO)CC4)C)([H])CC2)C)([H])[C@]([C@@](CC/C=C(C)/C)(C)O[C@@H]7O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)CO[C@H]8[C@@H]([C@H]([C@@H](O[C@@]9([H])[C@@H]([C@H]([C@H](O)CO9)O)O)CO8)O)O)([H])CC3)C

标准SMILES

CC1(C)[C@@H]2CC[C@]3(C)[C@H](C[C@@H](O)[C@@H]4[C@H](CC[C@@]34C)[C@](C)(CCC=C(C)C)O[C@@H]3O[C@H](CO[C@@H]4OC[C@H](O[C@@H]5OC[C@@H](O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)[C@@]2(C)CC[C@@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

性状

Powder or crystals

用途

For laboratory research purposes. Not for drug or household use.

信号词

Danger

InChIKey

KVMXBSSOCCPAOR-WWJNHZDPSA-N

危险类别(旧)

H301+H311+H331

存储要求

Keep in dark place,Inert atmosphere,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage.

安全信息

危险品分类

Acute toxicity, oral , acute toxicity, dermal and acute toxicity, inhalation
(Category 3)

UN No.

2811,2811,2811

化学稳定性

Stable under recommended storage conditions.

符号

SureRoute逆合成路线

1.  83459-41-0 逆合成路线 1

—
—
ACMFSX957
83459-41-0
来源: SureRoute

2.  83459-41-0 逆合成路线 2

—
—
ACMFSX957
83459-41-0
来源: SureRoute

3.  83459-41-0 逆合成路线 3

—
—
ACMFSX957
83459-41-0
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手